GlassScriptPhysician profile
Rakesh M Bhan
NPI 1508863069
$1,976.55
in general payments reported to CMS, 2019-2025
19 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $304 · 2021: $353 · 2022: $36.80 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $437.90 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.32 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $188.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.39 | 2019-2020 | |
| Cardiovascular Systems INC. | $141.86 | 2019-2020 | |
| Boston Scientific Corporation | $110.73 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $109.56 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $88.07 | 2021-2022 | |
| Medtronic, INC. | $74.77 | 2021 | |
| Amgen INC. | $74.55 | 2019 | |
| Chiesi USA, INC. | $64.42 | 2019 | |
| Amarin Pharma, INC. | $49.81 | 2019 | |
| Abbott Laboratories | $40.19 | 2019-2022 | |
| Pfizer INC. | $35.43 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $30.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $22.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.86 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.04 | 2019 | |
| Merck Sharp & Dohme LLC | $13.75 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Bhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.